Drugs / Antimicrobial decapeptide KSL-W
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02864901 | Oct → Nov 2016 | — | U.S. Army Medical Research and Development Command | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Antimicrobial decapeptide KSL-W | “Antimicrobial decapeptide KSL-W” NCT02864901 ↗ |
| Known as | KSL-W | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02864901 ↗ |
| Modality | Peptide | “Antimicrobial peptide, KSL-W, formulated as an antiplaque chewing gum (APCG)” PMID 32558314 ↗ Dec 2019 |